Skip to content
10-K

Annual Report

ACER THERAPEUTICS INC.

0000950170-23-009992

← back to feed
Filed
Mar 27, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 24, 2023 23.42M sh
Shares Diluted FY 2022 · Dec 31, 2022 15.77M sh
Shares Diluted FY 2022 · Dec 31, 2021 14.27M sh
Capex FY 2022 · Dec 31, 2022 $171.17K
Capex FY 2022 · Dec 31, 2021 $54.94K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$30.25M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$134.91K
Cash And Equivalents FY 2022 · Dec 31, 2022 $2.33M
Cash And Equivalents FY 2022 · Dec 31, 2021 $12.71M
Stockholders Equity FY 2022 · Dec 31, 2022 −$16.76M
Stockholders Equity FY 2022 · Dec 31, 2021 −$1.72M
Stockholders Equity FY 2022 · Dec 31, 2020 $8.22M
Current Liabilities FY 2022 · Dec 31, 2022 $18.95M
Current Liabilities FY 2022 · Dec 31, 2021 $29.11M
Total Liabilities FY 2022 · Dec 31, 2022 $28.39M
Total Liabilities FY 2022 · Dec 31, 2021 $37.98M
Current Assets FY 2022 · Dec 31, 2022 $3.52M
Current Assets FY 2022 · Dec 31, 2021 $28.09M
Total Assets FY 2022 · Dec 31, 2022 $11.62M
Total Assets FY 2022 · Dec 31, 2021 $36.26M
Eps Diluted FY 2022 · Dec 31, 2022 −$1.66
Eps Diluted FY 2022 · Dec 31, 2021 −$1.08
Eps Basic FY 2022 · Dec 31, 2022 −$1.66
Eps Basic FY 2022 · Dec 31, 2021 −$1.08
Rd Expense FY 2022 · Dec 31, 2022 $11.92M
Rd Expense FY 2022 · Dec 31, 2021 $6.51M
Net Income FY 2022 · Dec 31, 2022 −$26.24M
Net Income FY 2022 · Dec 31, 2021 −$15.37M
Operating Income FY 2022 · Dec 31, 2022 −$24.61M
Operating Income FY 2022 · Dec 31, 2021 −$15.95M
Revenue FY 2022 · Dec 31, 2021 $1.26M